New Alliance Between SC Johnson and the Global Fund to Combat Malaria and Protect Millions

New Partnership to Combat Malaria

In a significant development for global health, SC Johnson has announced a three-year partnership with the U.S. State Department and the Global Fund. The collaboration aims to broaden access to SC Johnson Guardian™, an innovative mosquito repellent designed to reduce malaria transmission, especially in Sub-Saharan Africa. This initiative hopes to safeguard the health of more than 60 million individuals over the next three years.

Fisk Johnson, the CEO of SC Johnson, expressed his gratitude for this collaboration during the announcement. He recalled the company's long-standing commitment to fighting malaria through affordable solutions. This partnership is expected to enhance the introduction and implementation of their mosquito repellent across approximately ten priority countries that bear the brunt of malaria incidence, thus protecting vulnerable communities.

Guardian Mosquito Repellent

SC Johnson Guardian™ is not just another pest control product; it's a cost-effective and non-electric device that provides up to a year of protection against mosquitoes. Given that malaria claims over 600,000 lives annually, predominantly affecting children under five in Sub-Saharan Africa, this partnership could be life-changing. Without swift distribution of new prevention tools, the global malaria burden is predicted to rise, making this alliance particularly crucial.

The manufacturing capabilities of SC Johnson have been bolstered in recent years, with two high-speed production lines launched in Nairobi, Kenya. This infrastructure can produce up to 20 million units annually, allowing for rapid distribution in high-risk areas. The partnership exemplifies how U.S. innovation, when combined with the Global Fund's global reach, can create equitable access to essential health tools.

The Role of Global Partnerships

The benefits of international partnerships cannot be understated. SC Johnson's commitment is further supported by the U.S. State Department's ongoing investments aimed at transforming global healthcare. Jeremy P. Lewin, the Acting Undersecretary for Humanitarian Assistance and Religious Freedom, highlighted the potential of U.S.-developed technologies to make tangible health improvements in underserved communities.

Peter Sands, the Executive Director of the Global Fund, emphasized that innovative alliances such as this are paramount in the fight against malaria. By accelerating access to new prevention tools, this collaboration aids countries in fortifying malaria prevention efforts and provides critical protection to vulnerable populations. The dual approach of using established interventions alongside new preventative technologies is essential in curbing the spread of malaria.

SC Johnson’s Commitment to Global Health

Founded in 1886 and headquartered in Racine, Wisconsin, SC Johnson is committed not only to producing high-quality household products but also to fostering a healthier and more sustainable world. The company has a long history of innovation and transparency, which is evident in the diverse array of trusted brands under its belt, including OFF!®, Raid®, and more.

To date, SC Johnson has invested over $120 million in the development and testing of the Guardian™ mosquito repellent without profit motivation. This effort is a testament to the company's dedication to public health, specifically in tackling pressing issues like malaria and other insect-borne diseases.

For more information on SC Johnson’s efforts to prevent malaria and their broader impact on global public health, you can visit their official website or follow them on social media platforms. SC Johnson believes in creating economic and educational opportunities globally, especially in regions with limited access to resources.

This new alliance is a hopeful step toward a malaria-free future, demonstrating how strategic collaborations in health can save lives and make a profound difference in the world.